Chemical inhibition of PARP1 synergized with the G-quadruplex ligand RHPS4 in HT29 xenografts could further inhibit tumor cell growth by preventing the repair of uncapped telomere ends (18). This evidence concerns the gene PARP1 and neoplasm.